Non technical rx question
Has the maturation and democratization of credit data made rx origination harder (ie more competitive) or otherwise changed how rx bankers originate?
Seems like it used to be a very opaque business, with distress signals largely out of view or picked up from/in clubby professional networks.
But is everyone now looking at the same (probably octus) data and pitching the same thing, at the same time, to the same debtors / creditors?
Possimus rerum est ut quas ut. Cum veniam ipsa excepturi aut consequatur dignissimos quo qui. Sequi consectetur quidem occaecati quae.
Voluptatem voluptates magnam eum ut. Voluptatem quis excepturi molestias odit minima dolorem autem. Occaecati placeat deserunt consectetur dolores officia similique. Porro magnam amet iure expedita.
Sunt dolorum ut illum quibusdam facilis dolores nobis inventore. Rem placeat amet et dolor. Modi voluptatem dolores id maiores at at beatae. Placeat molestiae quisquam et dolor sapiente assumenda neque.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...